NASDAQ:YTEN - Yield10 Bioscience Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.37 0.00 (0.00 %) (As of 08/19/2018 04:00 PM ET)Previous Close$1.37Today's Range$1.33 - $1.4252-Week Range$1.12 - $8.67Volume60,218 shsAverage Volume566,079 shsMarket Capitalization$13.56 millionP/E Ratio-0.42Dividend YieldN/ABeta3.02 Company ProfileAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts. Receive YTEN News and Ratings via Email Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Miscellaneous plastics products Sub-IndustryN/A SectorConsumer Staples SymbolNASDAQ:YTEN CUSIPN/A Webwww.yield10bio.com Phone617-583-1700 Debt Debt-to-Equity Ratio0.10 Current Ratio6.82 Quick Ratio6.82 Price-To-Earnings Trailing P/E Ratio-0.42 Forward P/E Ratio-0.51 P/E GrowthN/A Sales & Book Value Annual Sales$940,000.00 Price / Sales14.59 Cash FlowN/A Price / CashN/A Book Value$1.48 per share Price / Book0.93 Profitability EPS (Most Recent Fiscal Year)($3.29) Net Income$-9,390,000.00 Net Margins-1,377.53% Return on Equity-101.61% Return on Assets-76.35% Miscellaneous Employees20 Outstanding Shares10,010,000Market Cap$13.56 million Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions What is Yield10 Bioscience's stock symbol? Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN." When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work? Shares of Yield10 Bioscience reverse split on the morning of Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience Inc (NASDAQ:YTEN) announced its earnings results on Thursday, August, 9th. The specialty chemicals company reported ($0.24) EPS for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.03. The specialty chemicals company earned $0.29 million during the quarter. Yield10 Bioscience had a negative return on equity of 101.61% and a negative net margin of 1,377.53%. View Yield10 Bioscience's Earnings History. When is Yield10 Bioscience's next earnings date? Yield10 Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Yield10 Bioscience. What price target have analysts set for YTEN? 1 equities research analysts have issued 12-month price objectives for Yield10 Bioscience's stock. Their forecasts range from $7.00 to $7.00. On average, they expect Yield10 Bioscience's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 410.9% from the stock's current price. View Analyst Price Targets for Yield10 Bioscience. What is the consensus analysts' recommendation for Yield10 Bioscience? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Yield10 Bioscience. Who are some of Yield10 Bioscience's key competitors? Some companies that are related to Yield10 Bioscience include Senomyx (SNMX), Alkaline Water (WTER), Eastside Distilling (EAST), Willamette Valley Vineyards (WVVI), Future Fintech Group (FTFT), PwrCor (PWCO), Ocean Bio-Chem (OBCI), Farmmi (FAMI), China New Borun (BORN), Coffee (JVA), Big Rock Brewery (BRBMF), GLG Life Tech (GLGLF), TDH (PETZ), Mamamancini's (MMMB) and Burcon Nutrascience (BUR). Who are Yield10 Bioscience's key executives? Yield10 Bioscience's management team includes the folowing people: Dr. Oliver P. Peoples, Co-Founder, Pres, CEO & Director (Age 60)Dr. Anthony J. Sinskey, Co-Founder & Director (Age 78)Dr. Kristi Snell, VP of Research & Chief Science Officer (Age 50)Ms. Lynne H. Brum, VP of Planning & Communications and Sec. (Age 54)Mr. Charles B. Haaser, VP of Fin., Chief Accounting Officer & Treasurer (Age 62) Has Yield10 Bioscience been receiving favorable news coverage? News stories about YTEN stock have trended positive on Sunday, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Yield10 Bioscience earned a coverage optimism score of 0.32 on Accern's scale. They also gave media coverage about the specialty chemicals company an impact score of 42.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View Recent Headlines for Yield10 Bioscience. Who are Yield10 Bioscience's major shareholders? Yield10 Bioscience's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (3.84%). View Institutional Ownership Trends for Yield10 Bioscience. Which major investors are buying Yield10 Bioscience stock? YTEN stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Yield10 Bioscience. How do I buy shares of Yield10 Bioscience? Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Yield10 Bioscience's stock price today? One share of YTEN stock can currently be purchased for approximately $1.37. How big of a company is Yield10 Bioscience? Yield10 Bioscience has a market capitalization of $13.56 million and generates $940,000.00 in revenue each year. The specialty chemicals company earns $-9,390,000.00 in net income (profit) each year or ($3.29) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe. How can I contact Yield10 Bioscience? Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected] MarketBeat Community Rating for Yield10 Bioscience (NASDAQ YTEN)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 103 (Vote Outperform)Underperform Votes: 143 (Vote Underperform)Total Votes: 246MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe YTEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YTEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/19/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?